Advanced catheter developer Spinal Singularity said yesterday it received a grant from the Triumph Foundation it plans to use to support upcoming clinical trials of its Connected Catheter, and said that it has added a number of new locations to its current trial of the device.
The Connected Catheter is a smart catheter designed for adult men with chronic urinary retention or neurogenic lower urinary tract dysfunction, the San Clemente, Calif.-based company said.
“I am so excited to honor Derek and Spinal Singularity with this Employment Achievement Award. The work they are doing to help catheter users could have a massive impact on the quality of life for people with spinal injury and we are so happy to support this cause,” Triumph Foundation CEO & founder Andrew Skinner said in a prepared statement.
Spinal Singularity said it has added a number of sites to its current feasibility trial of the device, including Los Angeles’ West Coast Urology, Phoenix’s Northwest Urology, Minneapolis’ Metro Urology and Mt. Laurel, N.J.’s New Jersey Urology clinics.
“Fundraising is tough for any startup. We have had very promising results in the clinic thus far and are so excited to launch our next clinical study. Once we collect enough data from this study we plan to file for CE Mark Approval and FDA 510(k) clearance,” Spinal Singularity founder & CTO Derek Herrera said in a press release.
In March, Spinal Singularity said that it launched a clinical feasibility trial of its Connected Catheter.
